Metformin Treatment Prevents Sedentariness Related Damages in Mice
Metformin (METF), historical antihyperglycemic drug, is a likely candidate for lifespan extension, treatment and prevention of sedentariness damages, insulin resistance, and obesity. Skeletal muscle is a highly adaptable tissue, capable of hypertrophy response to resistance training and of regenerat...
Saved in:
| Main Authors: | Pamela Senesi, Anna Montesano, Livio Luzi, Roberto Codella, Stefano Benedini, Ileana Terruzzi |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2016-01-01
|
| Series: | Journal of Diabetes Research |
| Online Access: | http://dx.doi.org/10.1155/2016/8274689 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Metformin Counteracts HCC Progression and Metastasis Enhancing KLF6/p21 Expression and Downregulating the IGF Axis
by: Fernanda Vacante, et al.
Published: (2019-01-01) -
L-Carnitine: An Antioxidant Remedy for the Survival of Cardiomyocytes under Hyperglycemic Condition
by: Fernanda Vacante, et al.
Published: (2018-01-01) -
Moderate Intensity Training Impact on the Inflammatory Status and Glycemic Profiles in NOD Mice
by: Roberto Codella, et al.
Published: (2015-01-01) -
Effect of Sugar versus Mixed Breakfast on Metabolic and Neurofunctional Responses in Healthy Individuals
by: Roberto Codella, et al.
Published: (2017-01-01) -
Metformin for the chemoprophylaxis of cancer: an update systematic review about the role of metformin in cancer prevention.
by: Mirella Nardo, et al.
Published: (2020-01-01)